Comprehensive review on betulin as a potent anticancer agent

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Król, Sylwia Katarzyna ^a   Kiełbus, Michał ^a   Rivero Müller, Adolfo ^a,b,c   Stepulak, Andrzej ^a,d  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b UNIVERSITY OF TURKU   (Finland)

^c ÅBO AKADEMI UNIVERSITY   (Finland)

^d MSW Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETULIN; CASPASE 3; CASPASE 7; CASPASE 9; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; TRITERPENE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG PURIFICATION; DRUG PURITY; DRUG SAFETY; ENZYME ACTIVITY; HUMAN; IC50; IN VITRO STUDY; IN VIVO STUDY; METASTASIS INHIBITION; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SKIN FIBROBLAST; TUMOR INVASION; ANIMAL; METABOLISM; NEOPLASMS; TUMOR CELL LINE;

BETULACEAE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; HUMANS; NEOPLASMS; TRITERPENES;

EID: 84926512810     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/584189     Document Type: Article

References (81)

1. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008," International Journal of Cancer, Vol. 127, no. 12, pp. 2893-2917, 2010.
2. A. Jemal, M. M. Center, C. DeSantis, and E. M. Ward, "Global patterns of cancer incidence and mortality rates and trends," Cancer Epidemiology Biomarkers and Prevention, Vol. 19, no. 8, pp. 1893-1907, 2010.
3. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, "Global cancer statistics," CA Cancer Journal for Clinicians, Vol. 61, no. 2, pp. 69-90, 2011.
4. B. Joseph, P. Marchetti, P. Formstecher, G. Kroemer, R. Lewensohn, and B. Zhivotovsky, "Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment," Oncogene, Vol. 21, no. 1, pp. 65-77, 2002.
5. D. J. Newman, G. M. Cragg, and K. M. Snader, "The influence of natural products upon drug discovery," Natural Product Reports, Vol. 17, no. 3, pp. 215-234, 2000.
6. J. D. McChesney, S. K. Venkataraman, and J. T. Henri, "Plant natural products: Back to the future or into extinction?" Phytochemistry, Vol. 68, no. 14, pp. 2015-2022, 2007.
7. D. J. Newman and G. M. Cragg, "Natural products as sources of new drugs over the last 25 years," Journal of Natural Products, Vol. 70, no. 3, pp. 461-477, 2007.
8. N. H. Oberlies and D. J. Kroll, "Camptothecin and taxol: historic achievements in natural products research," Journal of Natural Products, Vol. 67, no. 2, pp. 129-135, 2004.
9. R. van der Heijden, D. I. Jacobs, W. Snoeijer, D. Hallard, and R. Verpoorte, "The Catharanthus alkaloids: pharmacognosy and biotechnology," Current Medicinal Chemistry, Vol. 11, no. 5, pp. 607-628, 2004.
10. F. Bouvier, A. Rahier, and B. Camara, "Biogenesis, molecular regulation and function of plant isoprenoids," Progress in Lipid Research, Vol. 44, no. 6, pp. 357-429, 2005.
11. S. Alakurtti, T. Mäkelä, S. Koskimies, and J. Yli-Kauhaluoma, "Pharmacological properties of the ubiquitous natural product betulin," European Journal of Pharmaceutical Sciences, Vol. 29, no. 1, pp. 1-13, 2006.
12. M. N. Laszczyk, "Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy," Planta Medica, Vol. 75, no. 15, pp. 1549-1560, 2009.
13. M. Drag-Zalesinska, J. Kulbacka, J. Saczko et al., "Esters of betulin and betulinic acid with amino acids have improved water solubility and are selectively cytotoxic toward cancer cells," Bioorganic and Medicinal Chemistry Letters, Vol. 19, no. 16, pp. 4814-4817, 2009.
14. J. Patočka, "Biologically active pentacyclic triterpenes and their current medicine signification," Journal of Applied Biomedicine, Vol. 10, no. 3, pp. 7-12, 2012.
15. R. Ekman, "The submarin monomers and triterpenoids from the outer bark of betula verrucosa EHRH," Holzforschung, Vol. 37, no. 4, pp. 205-211, 1983.
16. C. M. Şoica, C. A. Dehelean, C. Peev et al., "Physico-chemical comparison of betulinic acid, betulin and birch bark extract and in vitro investigation of their cytotoxic effects towards skin epidermoid carcinoma (A431), breast carcinoma (MCF7) and cervix adenocarcinoma (HeLa) cell lines," Natural Product Research, Vol. 26, no. 10, pp. 968-974, 2012.
17. P. N. Diouf, T. Stevanovic, and Y. Boutin, "The effect of extraction process on polyphenol content, triterpene composition and bioactivity of yellow birch (Betula alleghaniensis Britton) extracts," Industrial Crops and Products, Vol. 30, no. 2, pp. 297-303, 2009.
18. H. Gao, L. Wu, M. Kuroyanagi et al., "Antitumor-promoting constituents from Chaenomeles sinensis KOEHNE and their activities in JB6 mouse epidermal cells," Chemical and Pharmaceutical Bulletin, Vol. 51, no. 11, pp. 1318-1321, 2003.
19. B. Y. Hwang, H.-B. Chai, L. B. S. Kardono et al., "Cytotoxic triterpenes from the twigs of Celtis philippinensis," Phytochemistry, Vol. 62, no. 2, pp. 197-201, 2003.
20. M. Liu, S. Yeng, L. Jin, D. Hu, Z. Wu, and S. Yang, "Chemical constituents of the ethyl acetate extract of belamcanda chinensis (L.) DC roots and their antitumor activities," Molecules, Vol. 17, no. 5, pp. 6156-6169, 2012.
21. V. S. Prakash Chaturvedula, J. K. Schilling, R. K. Johnson, and D. G. I. Kingston, "New cytotoxic lupane triterpenoids from the twigs of Coussarea paniculata," Journal of Natural Products, Vol. 66, no. 3, pp. 419-422, 2003.
22. S. Yang, M. Liu, N. Liang, Q. Zhao, Y. Zhang, and W. Xue, "Discovery and antitumor activities of constituents from Cyrtomium fortumei (J.) Smith rhizomes," Chemistry Central Journal, Vol. 7, no. 1, article 24, 2013.
23. W. Rzeski, A. Stepulak, M. Szymański et al., "Betulin elicits anticancer effects in tumour primary cultures and cell lines in vitro," Basic and Clinical Pharmacology and Toxicology, Vol. 105, no. 6, pp. 425-432, 2009.
24. D.-Y. Wang, J. Liu, M.-Z. Yin et al., "Betulin induces apoptosis of HeLa cell lines in vitro and its possible mechanism," Tumor, Vol. 32, no. 4, pp. 234-238, 2012.
25. K. Hata, K. Hori, H. Ogasawara, and S. Takahashi, "Antileukemia activities of Lup-28-al-20(29)-en-3-one, a lupane triterpene," Toxicology Letters, Vol. 143, no. 1, pp. 1-7, 2003.
26. Y. Li, K. He, Y. Huang et al., "Betulin induces mitochondrial cytochrome c release associated apoptosis in human cancer cells," Molecular Carcinogenesis, Vol. 49, no. 7, pp. 630-640, 2010.
27. C. Gauthier, J. Legault, M. Lebrun, P. Dufour, and A. Pichette, "Glycosidation of lupane-type triterpenoids as potent in vitro cytotoxic agents," Bioorganic and Medicinal Chemistry, Vol. 14, no. 19, pp. 6713-6725, 2006.
28. C. Gauthier, J. Legault, S. Lavoie, S. Rondeau, S. Tremblay, and A. Pichette, "Synthesis and cytotoxicity of bidesmosidic betulin and betulinic acid saponins," Journal of Natural Products, Vol. 72, no. 1, pp. 72-81, 2009.
29. S. P. Jae, H. R. Si, K. K. Dae et al., "Anti-cancer effect of betulin on a human lung cancer cell line: a pharmacoproteomic approach using 2 D SDS PAGE coupled with nano-HPLC tandem mass spectrometry," Planta Medica, Vol. 75, no. 2, pp. 127-131, 2009.
30. S. Pacifico, M. Gallicchio, A. Fiorentino, A. Fischer, U. Meyer, and F. C. Stintzing, "Antioxidant properties and cytotoxic effects on human cancer cell lines of aqueous fermented and lipophilic quince (Cydonia oblonga Mill.) preparations," Food and Chemical Toxicology, Vol. 50, no. 11, pp. 4130-4135, 2012.
31. C. Mutai, D. Abatis, C. Vagias, D. Moreau, C. Roussakis, and V. Roussis, "Cytotoxic lupane-type triterpenoids from Acacia mellifera," Phytochemistry, Vol. 65, no. 8, pp. 1159-1164, 2004.
32. C. A. Dehelean, S. Feflea, J. Molnár, I. Zupko, and C. Soica, "Betulin as an antitumor agent tested in vitro on A431, HeLa and MCF7, and as an angiogenic inhibitor in vivo in the CAM assay," Natural Product Communications, Vol. 7, no. 8, pp. 981-985, 2012.
33. S. Boryczka, E. Bebenek, J. Wietrzyk et al., "Synthesis, structure and cytotoxic activity of new acetylenic derivatives of betulin," Molecules, Vol. 18, no. 4, pp. 4526-4543, 2013.
34. V. Amico, V. Barresi, D. Condorelli, C. Spatafora, and C. Tringali, "Antiproliferative terpenoids from almond hulls (Prunus dulcis): identification and structure-activity relationships," Journal of Agricultural and Food Chemistry, Vol. 54, no. 3, pp. 810-814, 2006.
35. J. Sarek, M. Kvasnica, M. Urban, J. Klinot, and M. Hajduch, "Correlation of cytotoxic activity of betulinines and their hydroxy analogues," Bioorganic and Medicinal Chemistry Letters, Vol. 15, no. 19, pp. 4196-4200, 2005.
36. M. Drag, P. Surowiak, D.-Z. Malgorzata, M. Dietel, H. Lage, and J. Oleksyszyn, "Comparision of the cytotoxic effects of birch bark extract, betulin and betulinic acid towards human gastric carcinoma and pancreatic carcinoma drug-sensitive and drugresistant cell lines," Molecules, Vol. 14, no. 4, pp. 1639-1651, 2009.
37. K. Hata, K. Hori, and S. Takahashi, "Differentiation- and apoptosis-inducing activities by pentacyclic triterpenes on a mouse melanoma cell line," Journal of Natural Products, Vol. 65, no. 5, pp. 645-648, 2002.
38. D. S. H. L. Kim, J. M. Pezzuto, and E. Pisha, "Synthesis of betulinic acid derivatives with activity against human melanoma," Bioorganic & Medicinal Chemistry Letters, Vol. 8, no. 13, pp. 1707-1712, 1998.
39. C. Şoica, C. Dehelean, C. Danciu et al., "Betulin complex in γ-cyclodextrin derivatives: properties and antineoplasic activities in in vitro and in vivo tumor models," International Journal of Molecular Sciences, Vol. 13, no. 11, pp. 14992-15011, 2012.
40. M. Urban, J. Sarek, M. Kvasnica, I. Tislerova, and M. Hajduch, "triterpenoid pyrazines and benzopyrazines with cytotoxic activity," Journal of Natural Products, Vol. 70, no. 4, pp. 526-532, 2007.
41. M. Urban, M. Vlk, P. Dzubak, M. Hajduch, and J. Sarek, "Cytotoxic heterocyclic triterpenoids derived from betulin and betulinic acid," Bioorganic and Medicinal Chemistry, Vol. 20, no. 11, pp. 3666-3674, 2012.
42. S. Jäger, M. N. Laszczyk, and A. Scheffler, "A preliminary pharmacokinetic study of betulin, the main pentacyclic triterpene from extract of outer bark of birch (Betulae alba cortex)," Molecules, Vol. 13, no. 12, pp. 3224-3235, 2008.
43. C. A. Dehelean, C. Şoica, I. Ledeţi et al., "Study of the betulin enriched birch bark extracts effects on human carcinoma cells and ear inflammation," Chemistry Central Journal, Vol. 6, no. 1, article 137, 2012.
44. M. Laszczyk, S. Jäger, B. Simon-Haarhaus, A. Scheffler, and C. M. Schempp, "Physical, chemical and pharmacological characterization of a new oleogel-forming triterpene extract from the outer bark of birch (Betulae cortex)," Planta Medica, Vol. 72, no. 15, pp. 1389-1395, 2006.
45. P. A. Krasutsky, "Birch bark research and development," Natural Product Reports, Vol. 23, no. 6, pp. 919-942, 2006.
46. C. A. Dehelean, S. Feflea, D. Gheorgheosu et al., "Antiangiogenic and anti-cancer evaluation of betulin nanoemulsion in chicken chorioallantoic membrane and skin carcinoma in Balb/c mice," Journal of Biomedical Nanotechnology, Vol. 9, no. 4, pp. 577-589, 2013.
47. M. Brown and L. D. Attardi, "The role of apoptosis in cancer development and treatment response," Nature Reviews Cancer, Vol. 5, no. 3, pp. 231-237, 2005.
48. S. Fulda and K. M. Debatin, "Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy," Oncogene, Vol. 25, no. 34, pp. 4798-4811, 2006.
49. S. Elmore, "Apoptosis: a review of programmed cell death," Toxicologic Pathology, Vol. 35, no. 4, pp. 495-516, 2007.
50. G. Del Poeta, A. Bruno, M. I. Del Principe et al., "Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia," Current Cancer Drug Targets, Vol. 8, no. 3, pp. 207-222, 2008.
51. J. Plati, O. Bucur, and R. Khosravi-Far, "Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities," Journal of Cellular Biochemistry, Vol. 104, no. 4, pp. 1124-1149, 2008.
52. I. N. Lavrik, "Regulation of death receptor-induced apoptosis induced via CD95/FAS and other death receptors," Molekuliarnaia Biologiia, Vol. 45, no. 1, pp. 173-179, 2011.
53. D. R. Green, R. A. Knight, G. Melino, A. Finazzi-Agro, and S. Orrenius, "Ten years of publication in cell death," Cell Death and Differentiation, Vol. 11, no. 1, pp. 2-3, 2004.
54. F. B. Mullauer, J. H. Kessler, and J. P. Medema, "Betulin is a potent anti-tumor agent that is enhanced-by cholesterol," PLoS ONE, Vol. 4, no. 4, article e1, Article ID e5361, 2009.
55. C. J. Sherr, "The pezcoller lecture: cancer cell cycles revisited," Cancer Research, Vol. 60, no. 14, pp. 3689-3695, 2000.
56. G. K. Schwartz and M. A. Shah, "Targeting the cell cycle: a new approach to cancer therapy," Journal of Clinical Oncology, Vol. 23, no. 36, pp. 9408-9421, 2005.
57. H. Harada, U. Yamashita, H. Kurihara, E. Fukushi, J. Kawabata, and Y. Kamei, "Antitumor activity of palmitic acid found as a selective cytotoxic substance in a marine red alga," Anticancer Research, Vol. 22, no. 5, pp. 2587-2590, 2002.
58. Y.-L. Cheng, W.-L. Chang, S.-C. Lee et al., "Acetone extract of Angelica sinensis inhibits proliferation of human cancer cells via inducing cell cycle arrest and apoptosis," Life Sciences, Vol. 75, no. 13, pp. 1579-1594, 2004.
59. J. Sun and R. Hai Liu, "Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells," Cancer Letters, Vol. 241, no. 1, pp. 124-134, 2006.
60. X. Hu, X. Zhang, S. Qiu, D. Yu, and S. Lin, "Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells," Biochemical and Biophysical Research Communications, Vol. 398, no. 1, pp. 62-67, 2010.
61. S. H. Oh, J. E. Choi, and S. C. Lim, "Protection of betulin against cadmium-induced apoptosis in hepatoma cells," Toxicology, Vol. 220, no. 1, pp. 1-12, 2006.
62. S.-I. Wada, A. Iida, and R. Tanaka, "Screening of triterpenoids isolated from Phyllanthus flexuosus for DNA topoisomerase inhibitory activity," Journal of Natural Products, Vol. 64, no. 12, pp. 1545-1547, 2001.
63. S. Simizu, M. Takada, K. Umezawa, and M. Imoto, "Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs," The Journal of Biological Chemistry, Vol. 273, no. 41, pp. 26900-26907, 1998.
64. D. E. Wood and E. W. Newcomb, "Caspase-dependent activation of calpain during drug-induced apoptosis," The Journal of Biological Chemistry, Vol. 274, no. 12, pp. 8309-8315, 1999.
65. B. H. Wang and G. M. Polya, "Selective inhibition of cyclic AMP-dependent protein kinase by amphiphilic triterpenoids and related compounds," Phytochemistry, Vol. 41, no. 1, pp. 55-63, 1996.
66. E. Tokunaga, E. Oki, A. Egashira et al., "Deregulation of the akt pathway in human cancer," Current Cancer Drug Targets, Vol. 8, no. 1, pp. 27-36, 2008.
67. P. J. Roberts and C. J. Der, "Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer," Oncogene, Vol. 26, no. 22, pp. 3291-3310, 2007.
68. R. Muceniece, K. Saleniece, U. Riekstina, L. Krigere, G. Tirzitis, and J. Ancans, "Betulin binds to melanocortin receptors and antagonizes α-melanocyte stimulating hormone induced cAMP generation in mouse melanoma cells," Cell Biochemistry and Function, Vol. 25, no. 5, pp. 591-596, 2007.
69. Y. Xia, R. Muceniece, and J. E. S. Wikberg, "Immunological localisation of melanocortin 1 receptor on the cell surface of WM266-4 human melanoma cells," Cancer Letters, Vol. 98, no. 2, pp. 157-162, 1996.
70. V. Chhajlani, "Distribution of cDNA for melanocortin receptor subtypes in human tissues," Biochemistry and Molecular Biology International, Vol. 38, no. 1, pp. 73-80, 1996.
71. J. E. S. Wikberg, R. Muceniece, I. Mandrika et al., "New aspects on the melanocortins and their receptors," Pharmacological Research, Vol. 42, no. 5, pp. 393-420, 2000.
72. A. Catania, S. Gatti, G. Colombo, and J. M. Lipton, "Targeting melanocortin receptors as a novel strategy to control inflammation," Pharmacological Reviews, Vol. 56, no. 1, pp. 1-29, 2004.
73. S. A. Ciurlea, C. Tiulea, E. Csanyi et al., "A pharmacotoxicological evaluation of a betulin topical formulation tested on C57BL/6J mouse experimental nevi and skin lesions," Studia Universitatis Vasile Goldis Arad, Seria Stiintele Vietii, Vol. 20, no. 4, pp. 5-9, 2010.
74. A. K. Zhanataev, G. A. Presnova, A. N. Chistyakov, and A. D. Durnev, "Effect of Betula bark extract on spontaneous and induced mutagenesis in mice," Bulletin of Experimental Biology and Medicine, Vol. 138, no. 5, pp. 475-478, 2004.
75. C. Huyke, M. Laszczyk, A. Scheffler, R. Ernst, and C. M. Schempp, "Treatment of actinic keratoses with birch bark extract: a pilot study," JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Vol. 4, no. 2, pp. 132-136, 2006.
76. C. Huyke, J. Reuter, M. Rödig et al., "Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study," Journal of the German Society of Dermatology, Vol. 7, no. 2, pp. 128-134, 2009.
77. W. Fu and C. J. Cocherell, "The actinic (solar) keratosis: a 21st-century perspective," Archives of Dermatology, Vol. 139, no. 1, pp. 66-70, 2003.
78. R. I. Ceilley and J. L. Jorizzo, "Current issues in the management of actinic keratosis," Journal of the American Academy of Dermatology, Vol. 68, no. 1, supplement 1, pp. S28-S38, 2013.
79. R. G. Glogau, "The risk of progression to invasive disease," Journal of the American Academy of Dermatology, Vol. 42, no. 1, part 2, pp. S23-S24, 2000.
80. C. M. Şoica, C. I. Peev, S. Ciurlea, R. Ambrus, and C. Dehelean, "Physico-chemical and toxicological evaluations of betulin and betulinic acid interactions with hydrophilic cyclodextrins," Farmacia, Vol. 58, no. 5, pp. 611-619, 2010.
81. H. M. Wang, C. M. Şoica, and G. Wenz, "A comparison investigation on the solubilization of betulin and betulinic acid in cyclodextrin derivatives," Natural Product Communications, Vol. 7, no. 3, pp. 289-291, 2012.